Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q96QS6
UPID:
PSKH2_HUMAN
Alternative names:
Protein serine kinase H2
Alternative UPACC:
Q96QS6; A0AV22
Background:
Serine/threonine-protein kinase H2, also known as Protein serine kinase H2, plays a crucial role in various cellular processes, including cell cycle regulation, apoptosis, and DNA repair. Its ability to phosphorylate serine and threonine residues makes it a key player in signal transduction pathways, influencing cell proliferation and survival.
Therapeutic significance:
Understanding the role of Serine/threonine-protein kinase H2 could open doors to potential therapeutic strategies. Its involvement in fundamental cellular mechanisms positions it as a promising target for drug discovery, aiming to modulate its activity in diseases where its function is dysregulated.